Infection Control Market Size, Trends and Growth Analysis By Type (Disinfection Products, Sterilization Products, & Services), by End-U.S.er (Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies) – Global Forecast Till 2030

Infectious Diseases Market Overview

Market Research Future (MRFR) projects the infection control market to expand at an approximate rate of 3.70% between 2020 and 2030.

Infectious diseases are surging in number worldwide, caused by pathogenic microorganisms, like viruses, bacteria, fungi or parasites. The diseases are directly or indirectly spread from one individual to another, or can be caused from non-sterilized or infected medical or surgical devices that are used during treatment. These diseases can also be caused in infected environments of a healthcare facility. Therefore, to prevent the chances of these infections, infection control is the top preventable measure.

Surging cases of hospital-acquired infections, heightened number of surgeries, and chronic ailments’ rising prevalence among the burgeoning geriatric populace favor the infection control industry. The thriving medical device reprocessing sector adds value to the infection control market as well. With that said, soaring concerns with regard to the safety level of the reprocessed instruments could deter the expansion of the infection control industry in the given period.

Rise in procedures that use high intensity infection control and prevention, escalating number of government awareness campaigns and the rise in obesity, diabetes, heart, respiratory disorders and cancer will offer great opportunities to the top manufacturers.

Segmentation

The infection control market has been segmented on the basis of type and end-U.S.er.

On the basis of type, the global infection control market can be segmented into disinfection products, sterilization products and services, and others.

The disinfection product is categorized into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors.

Disinfectants are further categorized by type, by formulation, and by EPA classification.

Disinfectants, by type, are classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The disinfectant by formulation is categorized into disinfectant wipes, disinfectant liquids, and disinfectant sprays. EPA classification is categorized into low-level disinfectants, intermediate-level disinfectants, and high-level disinfectants.

Medical nonwovens are classified into surgical drapes, surgical gowns, sterilization wraps, and face masks. Disinfectors are classified into washer disinfectors, flusher disinfectors, and UV ray disinfectors. Endoscope reprocessors are classified into automated endoscope reprocessors, endoscope tracking systems, and other endoscopic reprocessing products.

Sterilization products and services are classified into sterilization equipment, contract sterilization services, by type, and consumables and accessories.

Sterilization equipment are segmented into heat sterilization equipment, low-temperature sterilization, filtration sterilization, and radiation sterilization. Heat sterilization equipment are categorized into moist heat sterilizers and dry heat sterilizers. The low-temperature sterilization is categorized into Ethylene Oxide Sterilizers (EtO), hydrogen peroxide sterilizers, ozone sterilizers, formaldehyde sterilizers, and other low-temperature sterilization.

Contract sterilization services, by type is segmented into Ethylene Oxide Sterilization (EtO) services, gamma sterilization services, e-beam sterilization services, steam sterilization services, and other contract sterilization services.

The consumables and accessories are segmented into sterilization indicators, sterilant cassettes, and other consumables and accessories.

On the basis of end-U.S.er, the global infection control market is segmented into hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others.

Figure 1: - Global Infection Control Market Share, by Region

  

Regional Analysis

The global infection control market consists of four regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region accounted for the largest market share of the global infection control market owing to the increasing awareness about chronic infections along with the growing number of service providers. These factors are driving the market growth in the region. Moreover, the U.S. contributes to a significant market share for the infection control industry.

The European infection control market is the second largest market followed by Asia Pacific. The Asia Pacific region is expected to exhibit the fastest growth throughout the forecast period owing to the growing healthcare expenditure, exceptional healthcare standards and infrastructure, and growing presence of outsourcing organizations across this region. For instance, a voluntary organization namely the Asia Pacific Society of Infection Control (APSIC) is working in collaborations and partnerships to facilitate the quality improvement and conducts infection control research for promoting cost-efficient practices throughout the Asia Pacific region. Moreover, the presence of various government organizations dedicated to improving the standards for infection control is among the significant factors contributing toward the growth of the Asia Pacific region.

The Middle Eastern region is expected to grow at a steady pace owing to factors such as the extensive development of the healthcare infrastructure and increasing R&D activities in the healthcare sector.

Infection Control Market Key Players

Some of the key players in the global infection control market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Pal Internation (U.K.), Nordion, Inc. (U.S.), Ahlstrom Corporation (Finland), Honeywell International, Inc. (U.S.), and others.

Recent Development 

March 2022

TELA Bio Inc. will be launching SiteGuard No Rinse Antimicrobial Solution that can be used in plastic reconstructive surgery. SiteGuard uses Next Science's XBIO Technology that facilitates post-operative and surgical site infection control by dealing with the biofilms that turn the bacteria more resilient to conventional disinfectants, host immune defenses, and antimicrobial agents.

February 2022

Morton Salt has partnered with Salt Science Inc., a renowned developer of sterilization and sanitation solutions, to launch chemical-based cleaners, offering consumers with efficient, more sustainable and easy-to-use options. The Morton branded series of electrolyzing bottles as well as applicators will enable the businesses and households to make disinfectants and cleaners instantly with just the use of tap water along with Morton Table Salt.

Intended Audience

• Pharmaceutical and biotechnology companies


• Contract Research Organizations (CROs)


• Contract Manufacturing Organizations (CMOs)


• Contract sterilization service providers


• Sterilization and disinfection service providers


• Clinical and Diagnostic Labs


• Regulatory bodies


• Medical device companies


• Food and beverage companies


• Healthcare providers


• Research and consulting firms


• Venture capitalists and investors 

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :